Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|June 13, 2013
Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapyStephen J Freedland, Leah Gerber, Julia Reid, et al.
Urologic Oncology|April 16, 2018
Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillanceDaniel W Lin, E David Crawford, Thomas Keane, et al.
British Journal of Cancer|October 16, 2018
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancerJai N Patel, Ioana Braicu, Kirsten M Timms, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast CancerMarie-Kristin von Wahlde, Kirsten M Timms, Anees Chagpar, et al.
World Journal of Urology|April 22, 2018
Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomyPriscilla Léon, Geraldine Cancel-Tassin, Sara Drouin, et al.
The American Journal of Gastroenterology|September 27, 2007
IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel diseaseRebecca L Roberts, Richard B Gearry, Jade E Hollis-Moffatt, et al.
Breast Cancer Research : BCR|December 6, 2014
Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypesKirsten M Timms, Victor Abkevich, Elisha Hughes, et al.
The Journal of Urology|February 11, 2014
Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomyJay T Bishoff, Stephen J Freedland, Leah Gerber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancerPierre Laurent-Puig, Anne Cayre, Gilles Manceau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 20, 2013
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinomaIgnacio I Wistuba, Carmen Behrens, Francesca Lombardi, et al.
Pageof 3